A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines

References

• Gillet, J.-P. Varma, S, Gottesman, MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst 2013; 105:452-8; PMID:23434901; http://dx.doi.org/10.1093/jnci/djt007
   PubMed Web of Science ®Google Scholar
• Sharma SV Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 2010; 10:241-53; PMID:20300105; http://dx.doi.org/10.1038/nrc2820
   PubMed Web of Science ®Google Scholar
• Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39:D945-50; PMID:20952405; http://dx.doi.org/10.1093/nar/gkq929
   PubMed Web of Science ®Google Scholar
• Barretina, J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483:603-7; PMID:22460905; http://dx.doi.org/10.1038/nature11003
   PubMed Web of Science ®Google Scholar
• Castle JC, Loewer M, Boegel S, de Graaf J, Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics 2014; 15:190; PMID:24621249; http://dx.doi.org/10.1186/1471-2164-15-190
   PubMed Web of Science ®Google Scholar
• Kim Y. Sette A, Peters B. Applications for T-cell epitope queries and tools in the immune epitope database and analysis resource, J Immunol Methods 2011; 374:62-9; PMID:21047510; http://dx.doi.org/10.1016/j.jim.2010.10.010
   PubMed Web of Science ®Google Scholar
• Dutoit V. Herold-Mende C, Hilf N, Schoor O, Beckhove P, Bucher J, Dorsch K, Flohr S, Fritsche J. Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy. Brain 2012; 135:1042-54; PMID:22418738; http://dx.doi.org/10.1093/brain/aws042
   PubMed Web of Science ®Google Scholar
• Khalili JS, Hanson RW, Szallasi Z. In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census. Oncoimmunology 2012; 1:1281-9; PMID:23243591; http://dx.doi.org/10.4161/onci.21511
   PubMed Web of Science ®Google Scholar
• Warren RL, Holt RA. A census of predicted mutational epitopes suitable for immunologic cancer control. Hum Immunol 2010; 71:245-54; PMID:20035814; http://dx.doi.org/10.1016/j.humimm.2009.12.007
   PubMed Web of Science ®Google Scholar
• Segal, N. H. Parsons DW, Peggs KS, Velculescu V, Kinzler KW, Vogelstein B, Allison JP. Epitope landscape in breast and colorectal cancer. Cancer Res 2008; 68:889-92; PMID:18245491; http://dx.doi.org/10.1158/0008-5472.CAN-07-3095
   PubMed Web of Science ®Google Scholar
• Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, et al. Exploiting the mutanome for tumor vaccination. Cancer Res 2012; 72:1081-91; PMID:22237626; http://dx.doi.org/10.1158/0008-5472.CAN-11-3722
   PubMed Web of Science ®Google Scholar
• Rammensee H-G, Singh-Jasuja H. HLA ligandome tumor antigen discovery for personalized vaccine approach. Expert Rev Vaccines 2013; 12:1211-17; PMID:24090147; http://dx.doi.org/10.1586/14760584.2013.836911
   PubMed Web of Science ®Google Scholar
• Helmberg W, Dunivin R, Feolo M. The reagent database at dbMHC. Tissue Antigens 2004; 63:142-8; PMID:14705985; http://dx.doi.org/10.1111/j.1399-0039.2004.00163.x
   PubMed Web of Science ®Google Scholar
• Band V. Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, Connolly J, Sager R. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 1990; 50:7351-7; PMID:1977518
   PubMed Web of Science ®Google Scholar
• Boegel S. Löwer M, Schäfer M, Bukur T, de Graaf J, Boisguérin V, Türeci O, Diken M, Castle JC, Sahin U. HLA typing from RNA-Seq sequence reads. Genome Med 2013; 4:102; http://dx.doi.org/10.1186/gm403
   PubMedGoogle Scholar
• Teh M, Hui KM. Modulation of MHC gene expression in human breast carcinoma cells by hormones. J Immunogenet 1989; 16:397-405 ; PMID:2639911; http://dx.doi.org/10.1111/j.1744-313X.1989.tb00487.x
   PubMedGoogle Scholar
• Algarra I García-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother 2004; 53:904-10; PMID:15069585; http://dx.doi.org/10.1007/s00262-004-0517-9
   PubMed Web of Science ®Google Scholar
• Atkins D, Ferrone S, Schmahl GE, Störkel, S, Seliger B. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol 2004; 171:885-9; PMID:14713847; http://dx.doi.org/10.1097/01.ju.0000094807.95420.fe
   PubMed Web of Science ®Google Scholar
• Britten CM, Meyer RG, Kreer T, Drexler I, Wölfel T, Herr W. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. J Immunol Methods 2002; 259:95-110; PMID:11730845; http://dx.doi.org/10.1016/S0022-1759(01)00499-9
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, Rabot M, Hilgert I, Mami-Chouaib F, Tabiasco J, et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci U S A 2002; 99:16963-68; PMID:12486241; http://dx.doi.org/10.1073/pnas.012681099
   PubMed Web of Science ®Google Scholar
• Ruiz-Cabello, F. et al. Molecular analysis of MHC-class-I alterations in human tumor cell lines. Int J Cancer Suppl 1991; 6:123-130; PMID:1906050; http://dx.doi.org/10.1002/ijc.2910470723
   PubMedGoogle Scholar
• Marincola FM, Shamamian P, Simonis TB, Abati A, Hackett J, O'Dea T, Fetsch P, Yannelli J, Restifo NP, Mulé JJ. Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J Immunother Emphasis Tumor Immunol 1994; 16:13-23; PMID:8081556; http://dx.doi.org/10.1097/00002371-199407000-00002
   PubMed Web of Science ®Google Scholar
• Schuler MM, Nastke M-D, Stevanovikć S. SYFPEITHI: database for searching and T-cell epitope prediction. Methods Mol Biol 2007; 409:75-93; PMID:18449993; http://dx.doi.org/10.1007/978-1-60327-118-9_5
   PubMedGoogle Scholar
• Thomsen M, Lundegaard C, Buus S, Lund O, Nielsen M. MHCcluster, a method for functional clustering of MHC molecules. Immunogenetics 2013; 65:655-65; PMID:23775223; http://dx.doi.org/10.1007/s00251-013-0714-9
   PubMed Web of Science ®Google Scholar
• Vigneron, N. Stroobant, V. Van den Eynde, Benoît J, van der Bruggen, Pierre. Database of T cell-defined human tumor antigens: the 2013 update. Cancer Immun 2013; 13:15; PMID:23882160
   PubMedGoogle Scholar
• Ito D, Visus C, Hoffmann TK, Balz V, Bier H, Appella E, Whiteside TL, Ferris RL, DeLeo AB. Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck. Int J Cancer 2007; 120:2618-24; PMID:17294448; http://dx.doi.org/10.1002/ijc.22584
   PubMed Web of Science ®Google Scholar
• Hughes P Marshall D, Reid Y, Parkes, H, Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?. BioTechniques 2007; 43:575, 577-8, 581-2 passim; http://dx.doi.org/10.2144/000112598
   Google Scholar
• Giacomini P, Giorda E, Pera C, Ferrara GB. An ID card for tumour cell lines: HLA typing can help. Lancet Oncol 2001; 2:658 ; PMID:11902535; http://dx.doi.org/10.1016/S1470-2045(01)00554-X
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153-158; PMID:17344846; http://dx.doi.org/10.1038/nature05610
   PubMed Web of Science ®Google Scholar
• Reva B. Revealing selection in cancer using the predicted functional impact of cancer mutations. Application to nomination of cancer drivers. BMC Genomics 2013; 14:Suppl 3:S8; PMID:23819556; http://dx.doi.org/10.1186/1471-2164-14-S3-S8
   PubMedGoogle Scholar
• Stratton MR Exploring the genomes of cancer cells: progress and promise. Science 2011; 331:1553-8; PMID:21436442; http://dx.doi.org/10.1126/science.1204040
   PubMed Web of Science ®Google Scholar
• Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med 2013; 19:747-52; PMID:23644516; http://dx.doi.org/10.1038/nm.3161
   PubMed Web of Science ®Google Scholar
• Matsushita, H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 2012; 482:400-4; PMID:22318521; http://dx.doi.org/10.1038/nature10755
   PubMed Web of Science ®Google Scholar
• Fritsch EF, Rajasagi M, Ott PA, Brusic V, Hacohen N, Wu CJ. HLA-binding properties of tumor neoepitopes in humans. Cancer Immunol Res 2014; 2(6):522-9; PMID:24894089; http://dx.doi.org/10.1158/2326-6066.CIR-13-0227
   PubMedGoogle Scholar
• Kreiter S, Castle JC, Türeci Ö, Sahin U. Targeting the tumor mutanome for personalized vaccination therapy. Oncoimmunology 2012; 1:768-9; PMID:22934277; http://dx.doi.org/10.4161/onci.19727
   PubMed Web of Science ®Google Scholar
• A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011; 9:e1001046; PMID:21526222; http://dx.doi.org/10.1371/journal.pbio.1001046.
   PubMedGoogle Scholar
• Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, Shames DS, Bergbower EA, Guan Y, Shin J, Guillory J. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 2012; 44:1111-6; PMID:22941189; http://dx.doi.org/10.1038/ng.2405
   PubMed Web of Science ®Google Scholar
• Schomburg I, Chang A, Placzek S, Söhngen C, Rother M, Lang M, Munaretto C, Ulas S, Stelzer M, Grote A, et al. BRENDA in 2013: integrated reactions, kinetic data, enzyme function data, improved disease classification: new options and contents in BRENDA. Nucleic Acids Res 2013; 41:D764-72; PMID:23203881; http://dx.doi.org/10.1093/nar/gks1049
   PubMed Web of Science ®Google Scholar
• Adams S, Robbins FM, Chen D, Wagage D, Holbeck SL, Morse HC 3rd, Stroncek D, Marincola FM. HLA class I and II genotype of the NCI-60 cell lines. J Transl Med 2005; 3:11; PMID:15748285; http://dx.doi.org/10.1186/1479-5876-3-11
   PubMed Web of Science ®Google Scholar
• Robinson, J. Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2013; 41:D1222-7; PMID:23080122; http://dx.doi.org/10.1093/nar/gks949
   PubMed Web of Science ®Google Scholar
• Public Health England. HLA-Typed Collection. Available at http://www.phe-culturecollections.org.uk/products/celllines/hlatyped/browse.jsp (last access: 21.02.2014)
   Google Scholar
• Paunić V, Gragert L, Madbouly A, Freeman J, Maiers M. Measuring ambiguity in HLA typing methods. PLoS ONE 2012; 7:e43585; PMID:22952712; http://dx.doi.org/10.1371/journal.pone.0043585
   PubMed Web of Science ®Google Scholar
• Mortazavi A, Williams BA, McCue K, Schaeffer, L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq, Nat Methods 2008; 5:621-8; PMID:18516045; http://dx.doi.org/10.1038/nmeth.1226
   PubMed Web of Science ®Google Scholar
• Lundegaard C. Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res 2008; 36:W509-12; PMID:18463140; http://dx.doi.org/10.1093/nar/gkn202
   PubMed Web of Science ®Google Scholar
• Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005; 6:132; PMID:15927070; http://dx.doi.org/10.1186/1471-2105-6-132
   PubMed Web of Science ®Google Scholar
• Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994; 153:5586-92; PMID:7527444
   PubMed Web of Science ®Google Scholar
• Paul S. Weiskopf D, Angelo MA, Sidney J, Peters B, Sette A. HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. J Immunol 2013; 191:5831-9; PMID:24190657; http://dx.doi.org/10.4049/jimmunol.1302101
   PubMed Web of Science ®Google Scholar